Pharmacia Cytotec Use For Labor Induction Reaffirmed By ACOG
Executive Summary
The American College of Obstetricians & Gynecologists is reaffirming its guidelines supporting the use of Pharmacia/Searle's Cytotec (misoprostol) for the induction of labor.
You may also be interested in...
RU-486 Lower-Dose, Home-Administered Misoprostol Being Evaluated
The Population Council is planning a trial to demonstrate that a 200 mg dose of the abortifacient Mifeprex is effective and that the misoprostol component of the regimen can be safely used at home.
RU-486 Lower-Dose, Home-Administered Misoprostol Being Evaluated
The Population Council is planning a trial to demonstrate that a 200 mg dose of the abortifacient Mifeprex is effective and that the misoprostol component of the regimen can be safely used at home.
Searle/FDA Cytotec Labeling Negotiations Continue Ahead Of Mifeprex Launch
FDA is continuing to negotiate with Searle regarding changes to labeling of its gastric ulcer treatment Cytotec (misoprostol), which is an essential component of the recently approved Mifeprex (mifepristone, RU-486) regimen for termination of pregnancy.